✦ LIBER ✦

Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma

✍ Scribed by Ribatti, D; Nico, B; Vacca, A

Book ID: 110070476
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 231 KB
Volume: 25
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1209456

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of the Bone Marrow Microenvironment

Role of the Bone Marrow Microenvironment in Multiple Myeloma

✍ G. David Roodman 📂 Article 📅 2002 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 123 KB

Targeting the bone microenvironment in m

Targeting the bone microenvironment in multiple myeloma

✍ G. David Roodman 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 166 KB

The bone marrow stromal microenvironment

The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro

✍ Cheung, W-C; Van Ness, B 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 206 KB

Neighboring adipocytes participate in th

Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells

✍ Caers, J; Deleu, S; Belaid, Z; De Raeve, H; Van Valckenborgh, E; De Bruyne, E; D 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 223 KB

The selective adhesion molecule inhibito

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications

✍ Klaus Podar; Alexander Zimmerhackl; Mariateresa Fulciniti; Giovanni Tonon; Ursul 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

P130 Angiogenic factor levels in bone ma

P130 Angiogenic factor levels in bone marrow and serum of multiple myeloma patients are not applicable to predict response to chemotherapy

✍ Gy. Vadász; G. Radványi; I. Tárkányi; S. Baráth; M. Udvardy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

showed diffuse large B-cell lymphoma. She developed complete remission after treatment with 6 cycles R-CHOP (rituximab, and reduced doses of cyclophosphamide, vincristin, adriablastin, methylprednisolone). SLE became inactive and her symptoms of vasculitis resolved. ## Conclusion: We are bringing